Correction to: Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation

In the original publication of the article, the authors found few errors and the corrections are given below:

Bibliographische Detailangaben

Veröffentlicht in:	Cancer chemotherapy and pharmacology 2020, Vol.85 (1), p.237-239
Hauptverfasser:	Yamaguchi, Ou, Kaira, Kyoichi, Mouri, Atsuto, Shiono, Ayako, Hashimoto, Kosuke, Miura, Yu, Nishihara, Fuyumi, Murayama, Yoshitake, Kobayashi, Kunihiko, Kagamu, Hiroshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Research Correction Epidermal growth factor receptors Lung cancer Medicine Medicine & Public Health Mutation Non-small cell lung carcinoma Oncology Pharmacology/Toxicology Small cell lung carcinoma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!